RP-7214 is under clinical development by Rhizen Pharmaceuticals and currently in Phase II for Coronavirus Disease 2019 (COVID-19).

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

An Oklahoma Medical Research Foundation physician-scientist is advancing research on a saliva test to diagnose Sjögren’s ...

For women in midlife, dry eyes can becomes even more prevalent, with approximately 61% of perimenopausal or menopausal women ...

Many people notice their nose feels dry and clogged with crusty lumps, especially after being in dusty or dry places, but few ...